Earnings Preview: Iovance Biotherapeutics
Portfolio Pulse from Benzinga Insights
Iovance Biotherapeutics (NASDAQ:IOVA) is set to release its quarterly earnings report on Tuesday, 2023-11-07. Analysts estimate an EPS of $-0.45. The company's past performance shows it beat EPS estimates last quarter, leading to a 6.44% increase in share price. However, the stock has been down 48.37% over the last 52-week period.
November 06, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Iovance Biotherapeutics is expected to report an EPS of $-0.45. The company's stock price increased by 6.44% after beating EPS estimates last quarter, but it has been down 48.37% over the last 52 weeks.
The company's earnings report could potentially impact the stock price. Last quarter, the company beat EPS estimates, leading to a 6.44% increase in share price. However, the stock has been down 48.37% over the last 52 weeks, which could indicate investor skepticism. The impact of the earnings report will depend on whether the company meets or exceeds the estimated EPS and the guidance it provides for the next quarter.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100